Cargando…
Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis
BACKGROUND: Increasing evidence indicates that the gut microbiota contributes to the occurrence and development of metabolic diseases. However, little is known about the effects of commonly used antidiabetic agents on the gut microbiota. In this study, we investigated the roles of dipeptidyl peptida...
Autores principales: | Liao, Xiaoyu, Song, Lingyu, Zeng, Benhua, Liu, Bingyao, Qiu, Yuyang, Qu, Hua, Zheng, Yi, Long, Min, Zhou, Houdi, Wang, Yuan, Du, Yingxuan, Xu, Jing, Shen, Rufei, Tong, Qiang, Cai, Leiqin, Li, Xing, Guo, Shaodong, Yang, Gangyi, Zhu, Zhiming, Pu, Xiaoyun, Wei, Hong, Zheng, Hongting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603491/ https://www.ncbi.nlm.nih.gov/pubmed/30922964 http://dx.doi.org/10.1016/j.ebiom.2019.03.057 |
Ejemplares similares
-
Metformin Targets Foxo1 to Control Glucose Homeostasis
por: Guo, Xiaoqin, et al.
Publicado: (2021) -
DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Wang, Qixian, et al.
Publicado: (2018) -
Microbiota: A potential orchestrator of antidiabetic therapy
por: Liu, Bingyao, et al.
Publicado: (2023) -
Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery
por: Lu, Zongshi, et al.
Publicado: (2018) -
Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
por: Li, Xing, et al.
Publicado: (2018)